Macrophage oxysterols and their binding proteins: Roles in atherosclerosis

Current Opinion in Lipidology

Volumn 23, Issue 5, 2012, Pages 462-470

  Olkkonen, Vesa M ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

apoptosis; atherosclerosis; inflammation; lipid metabolism; liver X receptors; OSBP; oxysterol

Indexed keywords

BINDING PROTEIN; CHOLESTEROL HYDROXYLASE; LIVER X RECEPTOR; OXYGENASE; OXYSTEROL; OXYSTEROL BINDING PROTEIN; POLYPHOSPHOINOSITIDE; STEROL; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; CELL FUNCTION; CELL SURVIVAL; CHOLESTEROL TRANSPORT; CYTOPLASM; HUMAN; LIPID METABOLISM; MACROPHAGE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; ATHEROSCLEROSIS; CELL SURVIVAL; CYTOPLASM; HUMANS; HYDROXYCHOLESTEROLS; INFLAMMATION; KETOCHOLESTEROLS; LIPID METABOLISM; MACROPHAGES; ORPHAN NUCLEAR RECEPTORS; PLAQUE, ATHEROSCLEROTIC; RECEPTORS, STEROID; SIGNAL TRANSDUCTION;

EID: 84866325411     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0b013e328356dba0     Document Type: Review

References (112)

1. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006; 6:508-519. (Pubitemid 43980523)
2. Tabas I, Williams KJ, Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007; 116:1832-1844. (Pubitemid 350287108)
3. Kruth HS. Receptor-independent fluid-phase pinocytosis mechanisms for induction of foam cell formation with native low-density lipoprotein particles. Curr Opin Lipidol 2011; 22:386-393.
4. Björkhem I, Diczfalusy U. Oxysterols: friends, foes, or just fellow passengers? Arterioscler Thromb Vasc Biol 2002; 22:734-742.
5. Carpenter KL, Taylor SE, van der Veen C, et al. Lipids and oxidised lipids in human atherosclerotic lesions at different stages of development. Biochim Biophys Acta 1995; 1256:141-150.
6. Garcia-Cruset S, Carpenter KL, Guardiola F, Mitchinson MJ. Oxysterols in cap and core of human advanced atherosclerotic lesions. Free Radic Res 1999; 30:341-350. (Pubitemid 29248516)
7. Garcia-Cruset S, Carpenter KL, Guardiola F, et al. Oxysterol profiles of normal human arteries, fatty streaks and advanced lesions. Free Radic Res 2001; 35:31-41. (Pubitemid 32725623)
8. Maor I, Kaplan M, Hayek T, et al. Oxidized monocyte-derived macrophages in aortic atherosclerotic lesion from apolipoprotein E-deficient mice and from human carotid artery contain lipid peroxides and oxysterols. Biochem Bio-phys Res Commun 2000; 269:775-780. (Pubitemid 30440376)
9. Vaya J, Aviram M, Mahmood S, et al. Selective distribution of oxysterols in atherosclerotic lesions and human plasma lipoproteins. Free Radic Res 2001; 34:485-497. (Pubitemid 32492688)
10. Shibata N, Glass CK. Macrophages, oxysterols and atherosclerosis. Circ J 2010; 74:2045-2051.
11. Lordan S, Mackrill JJ, O'Brien NM. Oxysterols and mechanisms of apoptotic signaling: implications in the pathology of degenerative diseases. J Nutr Biochem 2009; 20:321-336.
12. Shimada K. Immune system and atherosclerotic disease: heterogeneity of leukocyte subsets participating in the pathogenesis of atherosclerosis. Circ J 2009; 73:994-1001.
13. Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models. Nat Rev Immunol 2008; 8:802-815.
14. Thorp E, Subramanian M, Tabas I. The role of macrophages and dendritic cells in the clearance of apoptotic cells in advanced atherosclerosis. Eur J Immunol 2011; 41:2515-2518.
15. Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol 2010; 10:36-46.
16. Biasi F, Leonarduzzi G, Vizio B, et al. Oxysterol mixtures prevent proapoptotic effects of 7-ketocholesterol in macrophages: implications for proatherogenic gene modulation. Faseb J 2004; 18:693-695.
17. Leonarduzzi G, Biasi F, Chiarpotto E, Poli G. Trojan horse-like behavior of a biologically representative mixture of oxysterols. Mol Aspects Med 2004; 25:155-167. (Pubitemid 38401939)
18. Monier S, Samadi M, Prunet C, et al. Impairment of the cytotoxic and oxidative activities of 7 beta-hydroxycholesterol and 7-ketocholesterol by esterification with oleate. Biochem Biophys Res Commun 2003; 303:814-824. (Pubitemid 36384928)
19. Rutherford LD, Gieseg SP. 7-Ketocholesterol is Not Cytotoxic to U937 Cells When Incorporated into Acetylated Low Density Lipoprotein. Lipids 2012; 47:239-247.
20. Massey JB, Pownall HJ. Structures of biologically active oxysterols determine their differential effects on phospholipid membranes. Biochemistry 2006; 45:10747-10758. (Pubitemid 44320490)
21. Olkkonen VM, Hynynen R. Interactions of oxysterols with membranes and proteins. Mol Aspects Med 2009; 30:123-133.
22. Lingwood D, Simons K. Lipid rafts as a membrane-organizing principle. Science 2010; 327:46-50.
23. Lordan S, O'Brien NM, Mackrill JJ. The role of calcium in apoptosis induced by 7beta-hydroxycholesterol and cholesterol-5beta, 6beta-epoxide. J Bio-chem Mol Toxicol 2009; 23:324-332.
24. Mackrill JJ. Oxysterols and calcium signal transduction. Chem Phys Lipids 2011; 164:488-495.
25. Rusinol AE, Thewke D, Liu J, et al. AKT/protein kinase B regulation of BCL family members during oxysterol-induced apoptosis. J Biol Chem 2004; 279:1392-1399. (Pubitemid 38082666)
26. Vejux A, Guyot S, Montange T, et al. Phospholipidosis and down-regulation of the PI3-K/PDK-1/Akt signalling pathway are vitamin E inhibitable events associated with 7-ketocholesterol-induced apoptosis. J Nutr Biochem 2009; 20:45-61.
27. Berthier A, Lemaire-Ewing S, Prunet C, et al. Involvement of a calcium-dependent dephosphorylation of BAD associated with the localization of Trpc-1 within lipid rafts in 7-ketocholesterol-induced THP-1 cell apoptosis. Cell Death Differ 2004; 11:897-905. (Pubitemid 39139748)
28. Berthier A, Lemaire-Ewing S, Prunet C, et al. 7-Ketocholesterol-induced apoptosis. Involvement of several pro-apoptotic but also antiapoptotic calcium-dependent transduction pathways. FEBS J 2005; 272:3093-3104. (Pubitemid 40904696)
29. Palozza P, Serini S, Verdecchia S, et al. Redox regulation of 7-ketocholes-terol-induced apoptosis by beta-carotene in human macrophages. Free Radic Biol Med 2007; 42:1579-1590. (Pubitemid 46590620)
30. Lim HK, Kang HK, Yoo ES, et al. Oxysterols induce apoptosis and accumulation of cell cycle at G(2)/M phase in the human monocytic THP-1 cell line. Life Sci 2003; 72:1389-1399.
31. Lordan S, Mackrill JJ, O'Brien NM. Involvement of Fas signalling in 7beta-hydroxycholesterol-and cholesterol-5beta, 6beta-epoxide-induced apopto-sis. Int J Toxicol 2008; 27:279-285. (Pubitemid 351892691)
32. Gao X, Raghavamenon AC, D'Auvergne O, Uppu RM. Cholesterol secoal-dehyde induces apoptosis in J774 macrophages via mitochondrial pathway but not involving reactive oxygen species as mediators. Biochem Biophys Res Commun 2009; 389:382-387.
33. Leonarduzzi G, Vizio B, Sottero B, et al. Early involvement of ROS overproduction in apoptosis induced by 7-ketocholesterol. Antioxid Redox Signal 2006; 8:375-380. (Pubitemid 43741309)
34. Ryan L, O'Callaghan YC, O'Brien NM. Generation of an oxidative stress precedes caspase activation during 7beta-hydroxycholesterol-induced apoptosis in U937 cells. J Biochem Mol Toxicol 2004; 18:50-59. (Pubitemid 38312723)
35. Li W, Dalen H, Eaton JW, Yuan XM. Apoptotic death of inflammatory cells in human atheroma. Arterioscler Thromb Vasc Biol 2001; 21:1124-1130. (Pubitemid 34215139)
36. Yuan XM, Li W, Brunk UT, et al. Lysosomal destabilization during macro-phage damage induced by cholesterol oxidation products. Free Radic Biol Med 2000; 28:208-218. (Pubitemid 30084013)
37. Ryan L, O'Callaghan YC, O'Brien NM. The role of the mitochondria in apoptosis induced by 7beta-hydroxycholesterol and cholesterol-5beta, 6be-ta-epoxide. Br J Nutr 2005; 94:519-525. (Pubitemid 41555491)
38. Calkin AC, Tontonoz P. Liver x receptor signaling pathways and atherosclerosis. Arterioscler Thromb Vasc Biol 2010; 30:1513-1518.
39. Im SS, Osborne TF. Liver x receptors in atherosclerosis and inflammation. Circ Res 2011; 108:996-1001.
40. Radhakrishnan A, Ikeda Y, Kwon HJ, et al. Sterol-regulated transport of SREBPsfrom endoplasmic reticulum toGolgi: Oxysterols block transport by binding to Insig. Proc Natl Acad Sci USA 2007; 104:6511-6518. (Pubitemid 47175533)
41. DeBose-Boyd RA. Feedback regulation of cholesterol synthesis: sterol-accelerated ubiquitination and degradation of HMG CoA reductase. Cell Res 2008; 18:609-621.
42. Jo Y, Lee PC, Sguigna PV, DeBose-Boyd RA. Sterol-induced degradation of HMG CoA reductase depends on interplay of two Insigs and two ubiquitin ligases, gp78 and Trc8. Proc Natl Acad Sci USA 2011; 108:20503-20508.
43. Fu X, Menke JG, Chen Y, et al. 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J Biol Chem 2001; 276:38378-38387.
44. Janowski BA, Willy PJ, Devi TR, et al. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 1996; 383:728-731. (Pubitemid 26360651)
45. Lehmann JM, Kliewer SA, Moore LB, et al. Activation of the nuclear receptor LXR by oxysterols defines a new hormone response pathway. J Biol Chem 1997; 272:3137-3140. (Pubitemid 27066798)
46. Berrodin TJ, Shen Q, Quinet EM, et al. Identification of 5alpha, 6alpha-epoxycholesterol as a novel modulator of liver X receptor activity. Mol Pharmacol 2010; 78:1046-1058.
47. Ayaori M, Yakushiji E, Ogura M, et al. Retinoicacid receptor agonists regulate expression of ATP-binding cassette transporter G1 in macrophages. Bio-chim Biophys Acta 2012; 1821:561-572.
48. Ozasa H, Ayaori M, Iizuka M, et al. Pioglitazone enhances cholesterol efflux from macrophages by increasing ABCA1/ABCG1 expressions via PPARgamma/LXRalpha pathway: findings from in vitro and ex vivo studies. Atherosclerosis 2011; 219:141-150.
49. Xu L, Shen S, Kim JK, et al. 25-hydroxycholesterol-3-sulfate attenuates inflammatory response via PPARg signaling in human THP-1 macrophages. Am J Physiol Endocrinol Metab 2012; 302:E788-E799.
50. Levin N, Bischoff ED, Daige CL, et al. Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists. Arterioscler Thromb Vasc Biol 2005; 25:135-142. (Pubitemid 40054266)
51. Peng D, Hiipakka RA, Xie JT, et al. A novel potent synthetic steroidal liver X receptor agonist lowers plasma cholesterol and triglycerides and reduces atherosclerosis in LDLR(\/\) mice. Br J Pharmacol 2011; 162:1792-1804.
52. Tangirala RK, Bischoff ED, Joseph SB, et al. Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Proc Natl Acad Sci USA 2002; 99:11896-11901. (Pubitemid 34994495)
53. Yan W, Zhang T, Cheng J, et al. Liver X receptor agonist methyl-3beta-hydroxy-5alpha, 6alpha-epoxycholanate attenuates atherosclerosis in apoli-poprotein E knockout mice without increasing plasma triglyceride. Pharmacology 2010; 86:306-312.
54. Feig JE, Pineda-Torra I, Sanson M, et al. LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression. J Clin Invest 2010; 120:4415-4424.
55. Li G, Biju KC, Xu X, et al. Macrophage LXRalpha gene therapy ameliorates atherosclerosis as well as hypertriglyceridemia in LDLR(\/\) mice. Gene Ther 2011; 18:835-841.
56. Navab M, Reddy ST, Van Lenten BJ, Fogelman AM. HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol 2011; 8:222-232.
57. Yvan-Charvet L, Wang N, Tall AR. Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses. Arterioscler Thromb Vasc Biol 2010; 30:139-143.
58. Hozoji-Inada M, Munehira Y, Nagao K, et al. Liver X receptor beta (LXRbeta) interacts directly with ATP-binding cassette A1 (ABCA1) to promote high density lipoprotein formation during acute cholesterol accumulation. J Biol Chem 2011; 286:20117-20124.
59. Engel T, Kannenberg F, Fobker M, et al. Expression of ATP binding cassette-transporter ABCG1 prevents cell death by transporting cytotoxic 7beta-hydroxycholesterol. FEBS Lett 2007; 581:1673-1680. (Pubitemid 46528932)
60. Terasaka N, Wang N, Yvan-Charvet L, Tall AR. High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apop-tosis by promoting efflux of 7-ketocholesterol via ABCG1. Proc Natl Acad Sci USA 2007; 104:15093-15098. (Pubitemid 47619598)
61. Xu M, Zhou H, Tan KC, et al. ABCG1 mediated oxidized LDL-derived oxysterol efflux from macrophages. Biochem Biophys Res Commun 2009; 390:1349-1354.
62. Tarling EJ, Bojanic DD, Tangirala RK, et al. Impaired development of atherosclerosis in Abcg1\/\Apoe\/\mice: identification of specific oxysterols that both accumulate in Abcg1\/\Apoe\/\tissues and induce apoptosis. Arterioscler Thromb Vasc Biol 2010; 30:1174-1180.
63. Meurs I, Lammers B, Zhao Y, et al. The effect of ABCG1 deficiency on atherosclerotic lesion development in LDL receptor knockout mice depends on the stage of atherogenesis. Atherosclerosis 2012; 221:41-47.
64. Iborra RT, Machado-Lima A, Castilho G, et al. Advanced glycation in macrophages induces intracellular accumulation of 7-ketocholesterol and total sterols by decreasing the expression of ABCA-1 and ABCG-1. Lipids Health Dis 2011; 10:172.
65. Lammers B, Zhao Y, Hoekstra M, et al. Augmented atherogenesis in LDL receptor deficient mice lacking both macrophage ABCA1 and ApoE. PLoS One 2011; 6:e26095.
66. Shi W, Wang X, Wong J, et al. Effect of macrophage-derived apolipoprotein E on hyperlipidemia and atherosclerosis of LDLR-deficient mice. Biochem Biophys Res Commun 2004; 317:223-229. (Pubitemid 38401988)
67. Zanotti I, Pedrelli M, Poti F, et al. Macrophage, but not systemic, apolipo-protein E is necessary for macrophage reverse cholesterol transport in vivo. Arterioscler Thromb Vasc Biol 2011; 31:74-80.
68. Babiker A, Andersson O, Lund E, et al. Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high density lipoprotein-mediated reverse cholesterol transport. J Biol Chem 1997; 272:26253-26261. (Pubitemid 27458836)
69. Babiker A, Dzeletovic S, Wiklund B, et al. Patients with atherosclerosis may have increased circulating levels of 27-hydroxycholesterol and cholestenoic acid. Scand J Clin Lab Invest 2005; 65:365-375.
70. Weingartner O, Laufs U, Bohm M, Lutjohann D. An alternative pathway of reverse cholesterol transport: the oxysterol 27-hydroxycholesterol. Atherosclerosis 2010; 209:39-41.
71. Gaus K, Dean RT, Kritharides L, Jessup W. Inhibition of cholesterol efflux by 7-ketocholesterol: comparison between cells, plasma membrane vesicles, and liposomes as cholesterol donors. Biochemistry 2001; 40:13002-13014. (Pubitemid 33026647)
72. Gelissen IC, Brown AJ, Mander EL, et al. Sterol efflux is impaired from macrophage foam cells selectively enriched with 7-ketocholesterol. J Biol Chem 1996; 271:17852-17860. (Pubitemid 26250763)
73. Brown AJ, Mander EL, Gelissen IC, et al. Cholesterol and oxysterol metabolism and subcellular distribution in macrophage foam cells. Accumulation of oxidized esters in lysosomes. J Lipid Res 2000; 41:226-237.
74. Erridge C, Webb DJ, Spickett CM. 25-Hydroxycholesterol, 7beta-hydro-xycholesterol and 7-ketocholesterol upregulate interleukin-8 expression independently of Toll-like receptor 1, 2, 4 or 6 signalling in human macrophages. Free Radic Res 2007; 41:260-266. (Pubitemid 46404468)
75. Lemaire-Ewing S, Berthier A, Royer MC, et al. 7beta-Hydroxycholesterol and 25-hydroxycholesterol-induced interleukin-8 secretion involves a calcium-dependent activation of c-fos via the ERK1/2 signaling pathway in THP-1 cells: Oxysterols-induced IL-8 secretion is calcium-dependent. Cell Biol Toxicol 2009; 25:127-139.
76. Lemaire-Ewing S, Prunet C, Montange T, et al. Comparison of the cytotoxic, pro-oxidant and pro-inflammatory characteristics of different oxysterols. Cell Biol Toxicol 2005; 21:97-114. (Pubitemid 41253203)
77. Yehuda H, Szuchman-Sapir A, Khatib S, et al. Human atherosclerotic plaque lipid extract promotes expression of proinflammatory factors in human monocytes and macrophage-like cells. Atherosclerosis 2011; 218:339-343.
78. Bauman DR, Bitmansour AD, McDonald JG, et al. 25-Hydroxycholesterol secreted by macrophages in response to Toll-like receptor activation suppresses immunoglobulin A production. Proc Natl Acad Sci USA 2009; 106:16764-16769.
79. Park K, Scott AL. Cholesterol 25-hydroxylase production by dendritic cells and macrophages is regulated by type I interferons. J Leukoc Biol 2010; 88:1081-1087.
80. Magenau A, Benzing C, Proschogo N, et al. Phagocytosis of IgG-coated polystyrene beads by macrophages induces and requires high membrane order. Traffic 2011; 12:1730-1743.
81. Gargiulo S, Sottero B, Gamba P, et al. Plaque oxysterols induce unbalanced up-regulation of matrix metalloproteinase-9 in macrophagic cells through redox-sensitive signaling pathways: Implications regarding the vulnerability of atherosclerotic lesions. Free Radic Biol Med 2011; 51:844-855.
82. Joseph SB, Castrillo A, Laffitte BA, et al. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat Med 2003; 9:213-219. (Pubitemid 36227724)
83. Hong C, Walczak R, Dhamko H, et al. Constitutive activation of LXR in macrophages regulates metabolic and inflammatory gene expression: identification of ARL7 as a direct target. J Lipid Res 2011; 52:531-539.
84. Treuter E. New wrestling rules of anti-inflammatory transrepression by oxysterol receptor LXR revealed. Cell Res 2011; 21:711-714.
85. Ghisletti S, Huang W, Jepsen K, et al. Cooperative NCoR/SMRT interactions establish a corepressor-based strategy for integration of inflammatory and anti-inflammatory signaling pathways. Genes Dev 2009; 23:681-693.
86. Huang W, Ghisletti S, Perissi V, et al. Transcriptional integration of TLR2 and TLR4 signaling at the NCoR derepression checkpoint. Mol Cell 2009; 35:48-57.
87. Venteclef N, Jakobsson T, Ehrlund A, et al. GPS2-dependent corepressor/SUMO pathways govern anti-inflammatory actions of LRH-1 and LXRbeta in the hepatic acute phase response. Genes Dev 2010; 24:381-395.
88. Ghisletti S, Huang W, Ogawa S, et al. Parallel SUMOylation-dependent pathways mediate gene-and signal-specific transrepression by LXRs and PPARgamma. Mol Cell 2007; 25:57-70. (Pubitemid 46049061)
89. Marathe C, Bradley MN, Hong C, et al. The arginase II gene is an anti-inflammatory target of liver X receptor in macrophages. J Biol Chem 2006; 281:32197-32206. (Pubitemid 46036774)
90. A-Gonzalez N, Bensinger SJ, Hong C, et al. Apoptotic cells promote their own clearance and immune tolerance through activation of the nuclear receptor LXR. Immunity 2009; 31:245-258.
91. Joseph SB, Bradley MN, Castrillo A, et al. LXR-dependent gene expression is important for macrophage survival and the innate immune response. Cell 2004; 119:299-309. (Pubitemid 39360910)
92. Valledor AF, Hsu LC, Ogawa S, et al. Activation of liver X receptors and retinoid X receptors prevents bacterial-induced macrophage apoptosis. Proc Natl Acad Sci USA 2004; 101:17813-17818. (Pubitemid 40051969)
93. Fontaine C, Rigamonti E, Nohara A, et al. Liver X receptor activation potentiates the lipopolysaccharide response in human macrophages. Circ Res 2007; 101:40-49. (Pubitemid 47094622)
94. Mogilenko DA, Kudriavtsev IV, Trulioff AS, et al. Modified Low Density Lipoprotein Stimulates Complement C3 Expression and Secretion via Liver X Receptor and Toll-like Receptor 4Activation inHuman Macrophages. JBiol Chem 2012; 287:5954-5968.
95. Anniss AM, Apostolopoulos J, Dworkin S, et al. An oxysterol-binding protein family identified in the mouse. DNA Cell Biol 2002; 21:571-580.
96. Jaworski CJ, Moreira E, Li A, et al. A family of 12 human genes containing oxysterol-binding domains. Genomics 2001; 78:185-196. (Pubitemid 34001422)
97. Lehto M, Laitinen S, Chinetti G, et al. The OSBP-related protein family in humans. J Lipid Res 2001; 42:1203-1213. (Pubitemid 32744243)
98. Im YJ, Raychaudhuri S, Prinz WA, Hurley JH. Structural mechanism for sterol sensing and transport by OSBP-related proteins. Nature 2005; 437:154-158. (Pubitemid 41613443)
99. Raychaudhuri S, Prinz WA. The diverse functions of oxysterol-binding proteins. Annu Rev Cell Dev Biol 2010; 26:157-177.
100. Ridgway ND. Oxysterol-binding proteins. Subcell Biochem 2010; 51:159-182.
101. Vihervaara T, Jansen M, Uronen RL, et al. Cytoplasmic oxysterol-binding proteins: sterol sensorsortransporters? Chem Phys Lipids 2011; 164:443-450.
102. Stefan CJ, Manford AG, Baird D, et al. Osh proteins regulate phosphoinositide metabolism at ER-plasma membrane contact sites. Cell 2011; 144:389-401.
103. Yan D, Jauhiainen M, Hildebrand RB, et al. Expression of Human OSBP-Related Protein 1L in Macrophages Enhances Atherosclerotic Lesion Development in LDL Receptor-Deficient Mice. Arterioscler Thromb Vasc Biol 27:1618-1624.
104. Vihervaara T, Uronen RL, Wohlfahrt G, et al. Sterol binding by OSBP-related protein 1L regulates late endosome motility and function. Cell Mol Life Sci 2011; 68:537-551.
105. Yan D, Mäyränpää MI, Wong J, et al. OSBP-related protein 8 (ORP8) suppresses ABCA1 expression and cholesterol efflux from macrophages. J Biol Chem 2008; 283:332-340.
106. Béaslas O, Vihervaara T, Li J, et al. Silencing of OSBP-related protein 8 (ORP8) modifies the macrophage transcriptome, nucleoporin p62 distribution, and migration capacity. Exp Cell Res 2012. [Epub ahead of print]
107. Lehto M, Mäyränpää MI, Pellinen T, et al. The R-Ras interaction partner ORP3 regulates cell adhesion. J Cell Sci 2008; 121:695-705. (Pubitemid 351524168)
108. Du X, Kumar J, Ferguson C, et al. A role for oxysterol-binding protein-related protein 5 in endosomal cholesterol trafficking. J Cell Biol 2011; 192:121-135.
109. Jansen M, Ohsaki Y, Rita Rega L, et al. Role of ORPs in sterol transport from plasma membrane to ER and lipid droplets in mammalian cells. Traffic 2011; 12:218-231.
110. Georgiev AG, Sullivan DP, Kersting MC, et al. Osh proteins regulate membrane sterol organization but are not required for sterol movement between the ER and PM. Traffic 2011; 12:1341-1355.
111. de Saint-Jean M, Delfosse V, Douguet D, et al. Osh4p exchanges sterols for phosphatidylinositol 4-phosphate between lipid bilayers. J Cell Biol 2011; 195:965-978.
112. Mousley CJ, Yuan P, Gaur NA, et al. A Sterol-Binding Protein Integrates Endosomal Lipid Metabolism with TOR Signaling and Nitrogen Sensing. Cell 2012; 148:702-715.